联邦法官可能批准70亿美元的Purdue Pharma-Sackler和解方案, A federal judge will likely approve a $7 billion Purdue Pharma-Sackler settlement, ending opioid lawsuits with family payouts, loss of control, and new oversight.

设立一名联邦破产法官,负责批准一项经修订的解决方案,要求萨克勒家族在15年内支付70亿美元,并放弃对普鲁杜制药的控制权。 A federal bankruptcy judge is set to approve a revised settlement requiring the Sackler family to pay up to $7 billion over 15 years and give up control of Purdue Pharma. 这项交易取代了最高法院驳回的前一项计划,允许非定居当事方采取法律行动,并授权公开披露公司文件。 The deal, replacing a previous plan rejected by the Supreme Court, permits non-settling parties to pursue legal action and mandates public disclosure of company documents. 定居点还禁止家庭从事今后与类阿片有关的生意,并实行监督,将利润直接用于打击类阿片危机。 The settlement also bars the family from future opioid-related business and introduces oversight to direct profits toward combating the opioid crisis. 该协议得到了各州、城市、部落和大多数受害者的支持,解决了自1999年以来涉及近90万例吸毒过量死亡的数千起诉讼。 Backed by states, cities, tribes, and most victims, the agreement addresses thousands of lawsuits linked to nearly 900,000 overdose deaths since 1999. 最后听证会定于星期二举行,预计将在2026年春季举行。 A final hearing is scheduled for Tuesday, with implementation expected by spring 2026.